Molecular Characterization of Proteus spp. from Patients Admitted to Hospitals in Erbil City

Authors

Treska Dh. Kamil, Department of Biology, Medical Microbiology, College of Science, Cihan University, Erbil, Kurdistan Region, IraqFollow
Sanaria F. Jarjes, Erbil Polytechnic UniversityFollow

Corresponding Author

Treska Dh. Kamil

Authors ORCID

0000-0002-3468-4346

Document Type

Research Article

Abstract

The study was carried out to detect the identity of Proteus spp. isolated from various clinical specimens in Erbil City by polymerase chain reaction (PCR) technique. Specimens were of urine, wounds swabs, burn swabs, vaginal swabs, ear swabs, eye swabs, and sputum. Fifty-one Proteus isolates, (47) Proteus mirabilis, and (4) Proteus vulgaris, were undergone PCR assay using specific primers, targeting the genes ureR and Urease C (ureC), that encode for urease enzyme as a virulence factor of Proteus species. It was found that all isolates of Proteus mirabilis yielded positive result for ureR gene with an amplicon length of 225 bp, as well as, all isolates of Proteus vulgaris exhibited positive PCR products on gel for ureC gene with an amplicon length of 263 bp. Our results indicate that ureR and ureC based PCR method seems to be an appropriate method for characterization of Proteus mirabilis and Proteus vulgaris respectively.

Keywords

Proteus mirabilis, Proteus vulgaris, Polymerase chain reaction, ureR, Urease C

How to Cite This Article

Kamil, Treska Dh. and Jarjes, Sanaria F. (2021) "Molecular Characterization of Proteus spp. from Patients Admitted to Hospitals in Erbil City," Polytechnic Journal: Vol. 11: Iss. 2, Article 15.
DOI: https://doi.org/10.25156/ptj.v11n2y2021.pp95-99

References

Adnan, M., I. H. Aziz and M. S. Al-Deresawi. 2014. Molecular detection of Proteus mirabilis using PCR technique among urinary tract infection patients. Iraqi J. Biotecnol. 13(2): 35-47.

Alatrash, A. M. and A. Al-Yaseen. 2017. Detection of ureR AND ureC among Proteus mirabilis. Asian J. Pharm. Clin. Res. 10(8): 386.

AL-Imam, M. and B. Al-Rubaii. 2016. The influence of some amino acids, vitamins and anti-inflammatory drugs on activity of chondroitinase produced by Proteus vulgaris caused urinary tract infection. Iraqi J. Sci. 57(4A): 2412-2421.

AL-Saadi, B. Q., S. J. Kadhum and S. H. Muhaiesen. 2015. Isolation of uropathogens from pediatric associated UTI, with special focus on the detection of Proteus vulgaris. Iraqi J. Biotechnol. 14(1): 77-84.

Armbruster, C. E. and H. L. Mobley. 2012. Merging mythology and morphology: The multifaceted lifestyle of Proteus mirabilis. Nat. Rev. Microbiol. 10: 743.

Desjardins, P. and D. Conklin. 2010. NanoDrop microvolume quantitation of nucleic acids. J. Vis. Exp. 45: 2565.

Feglo, P. K. S., Y. Gbedema, S. N. A. Quay, Y. Adu-Sarkodie and C. O. Okrah. 2010. Occurrence, species distribution and antibitics resistance of Proteus isolates: A case study at the Komfo Anokye teaching hospital in Ghana. Int. J. Pharma Sci. Res. 1(9): 347-352.

Jacobsen, S.M., D. J. Stickler, H. L. T. Mobley and M. E. Shirtliff. 2008. Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis. Clin. Microbiol. Rev. 21(1): 26-59.

Jones, B. D. and H. L. Mobley. 1988. Proteus mirabilis urease: Genetic organization, regulation, and expression of structural genes. J. Bacteriol. 170(8): 3342-3349.

Jones, S. M., J., Yerly, Y. Hu, H. Ceri and R. Martinuzzi. 2007. Structure of Proteus mirabilis biofilms grown in artificial urine and standard laboratory media. J. Microbiol. Lett. 268(1): 16-21.

Kamel, F. H. and S. F. Jarjes. 2015. Essentials of Bacteriology and Immunology. Erbil Polytechnic University, Iraq.

Kamil, T. D. and S. F. Jarjes. 2019. Isolation, identification and antibiotics susceptibility determination of Proteus species obtained from various clinical specimens in Erbil city. Polytech. J. 9(2): 86-92.

Latif, B., S. Z. Aleabdyn and I. Ahmed. 2017. A Comparative bacteriological and molecular study on some virulence factor of Proteus spp isolated from clinical and environment specimens. Int. J. Curr. Res. Aca. Rev. 5(5): 26-33.

Lee, J. and R. A. Deininger. 2000. Survival of bacteria after ozonation. J. Int. Ozone Assoc. 22(1): 65-75.

Li, X. and H. L. Mobley. 2002. Vaccines for Proteus mirabilis in urinary tract infection. Int. J. Antimicrob. Agents. 19: 461-465.

Limanskiĭ, A., V. Minukhin, O. Limanskaia, N. Pavlenko, M. Mishina and A. Tsygenenko. 2005. Species-specific detection of Proteus vulgaris and Proteus mirabilis by the polymerase chain reaction. Zh. Mikrobiol. Epidemiol. Immunobiol. 3: 33-39.

Lu, J., C. Perng, S. Lee. and C. Wan. 2000. Use of PCR with universal primers and restriction endonuclease digestions for detection and identification of common bacterial pathogens in cerebrospinal fluid. J. Clin. Microbiol. 38(6): 2076-2080.

Mobley, H. and G. R. Chippendale. 1990. Hemagglutinin, urease and hemolysin production by Proteus mirabilis in clinical sources. J. Infect. Dis. 161: 525-530.

Mobley, H. and R. Belas. 1995. Swarming and pathogenicity of Proteus mirabilis in the urinary tract. Trends Microbial. 3: 280-284.

Lu, J., C. Perng, S. Lee. and C. Wan. 2000. Use of PCR with universal primers and restriction endonuclease digestions for detection and identification of common bacterial pathogens in cerebrospinal fluid. J. Clin. Microbiol. 38(6): 2076-2080.

Mobley, H. and G. R. Chippendale. 1990. Hemagglutinin, urease and hemolysin production by Proteus mirabilis in clinical sources. J. Infect. Dis. 161: 525-530.

Mobley, H. and R. Belas. 1995. Swarming and pathogenicity of Proteus mirabilis in the urinary tract. Trends Microbial. 3: 280-284. Mobley, H., M. Island and P. R. Hausinger. 1995. Molecular biology of microbial ureases. Microbiol. Rev. 59: 451-480.

Mohammed, S. O., O. A. Elshahaby, E. E. Hafez, A. K. Mohammed and E. Ahmed. 2014. Characterization and purification of urease enzyme from new Proteus mirabilis strain. J. Adv. Sci. Res. 5: 8-11.

Nielubowicz, G. and H. Mobley. 2010. Hostpathogen interactions in urinary tract infections. Nat. Rev. Urol. 7: 430-441.

O’Hara, C. F. W. Brenner, A. G. Steigerwalt, B. C. Hill, B. P. Holmes, A. D. Grimont, P. M. Hawkey, J. L. Penner, J. M. Miller and D. J. Brenner. 2000. Classification of Proteus vulgaris biogroup 3 with recognition of Proteus hauseri sp. nov., nom. rev. and unnamed Proteus genomospecies 4, 5 and 6. Int. J. Syst. Evol. Microbiol. 50: 1869-1875.

Pal, N., N. Sharma, R. Sharma, S. Hooja and R. Maheshwari. 2014. Prevalence of multidrug (MDR) and extensively drug resistant (XDR) Proteus species in a tertiary care hospital, India. Int. J. Curr. Microbiol. Appl. Sci. 3: 243-252.

Poore, C. and H. Mobley. 2003. Differential regulation of the Proteus mirabilis urease gene cluster by UreR and H-NS. Microbiology. 149(12): 3383-3394.

Sambrook, J. and D. W. Rusell. 2001. Molecular Cloning: ALaboratory Manual. 3rd ed. Cold Spring Harbor, Laboratory Press, New York.

Schabereiter-Gurtner, C., S. Maca, S. Rölleke, K. Nigl, J. Lukas, A. Hirschl, W. Lubitz and T. Barisani-Asenbauer. 2001. 16S rDNAbased identification of bacteria from conjunctival swabs by PCR and DGGE fingerprinting. Invest. Ophthalmol. Vis. Sci. 42: 1164- 1171.

Shoket, H., S. Ali, R. K. Gupta and V. K. Mishra. 2014. Occurrence of Proteus mirabilis associated with vegetable samples in Dehradun, Uttarakhand, India. Int. J. Curr. Microbiol. Appl. Sci. 3(7): 958-961.

Zhang, W., Z. Niu, K. Yin, P. Liu and L. Chen. 2013. Quick identification and quantification of Proteus mirabilis by polymerase chain reaction (PCR) assays. Ann. Microbiol. 63: 683-689.

Publication Date

12-30-2021